Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“A step forward in personalizing pancreatic cancer treatment!
We were honored to present our latest work at JFHODs, where we unveiled for the first time the development of PANCprofiler, an innovative transcriptomic signature based on deconvolution, designed to detect multidrug-resistant cells within pancreatic tumors.
A great achievement by Nicolas Fraunhoffer and the Marseille Pancreatic Cancer Team!”
